FDA Allows Rx Companies To State Purpose On-Air; Marketers To Benefit From Openness

Prescription drug broadcast ads have been liberated from strict FDA advertising restrictions on "brand only" messages, which could only mention product brands - no indications. In response to growing requests from Rx manufacturers and some consumer advocacy groups for better explanations in broadcast Rx ads, the FDA has loosened its regulatory grip.